Waystar Holding Corp.

WAY

NASDAQHealthcareMedical - Healthcare Information Services

Open in GoAI

Latest quote

$26.48

+$0.71 · +2.76%

Company profile

Waystar Holding Corp. is dedicated to developing a cloud-based software platform designed to streamline financial transactions within the healthcare industry. Their comprehensive system offers a suite of functionalities, including pre-approving finances, supporting patients with billing, overseeing claims and payments, actively preventing and recovering denied claims, enhancing revenue capture, and providing insightful analytics and reporting. The company's main clientele operates within the healthcare sector. Established in 2017, Waystar Holding Corp. is headquartered in Lehi, Utah.

Waystar Holding Corp.

WAY

NASDAQHealthcareMedical - Healthcare Information Services

Open in GoAI

Latest quote

$26.48

+$0.71 · +2.76%

Oct 8, 4:00 PM ET

Latest quote

$26.48

+$0.71 · +2.76%

After-hours

$26.48

$0.00 · 0.00%

Oct 8, 4:43 PM ET

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

61/ 100

GoAI Score

Buy

Valuation

Deep Value

Sentiment

Bullish

Risk

Elevated Risk

Momentum

Weakening

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Company website

Industry: Medical - Healthcare Information Services
Sector: Healthcare
Headquarters: US
CEO: Matthew J. Hawkins
Listed since: Jun 7, 2024
Employees: 1,700

Market position

Day range

Current $26.48

$25.78$26.705

52-week range

Current $26.48

$17.26$40.35

Open: $25.78
Previous close: $25.77
Volume: 2.09M; 0.82× average
Average volume: 2.55M; Average daily volume
Market cap: 5.08B USD
Beta: 0.07; Market reference 1
50-day average: $24.8092; +6.73% above average
200-day average: $24.2807; +9.06% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 7.26B USD
P/E (TTM): 36.78×
P/B (TTM): 1.27×
P/S (TTM): 4.21×
EV / EBITDA: 18.61×
Earnings yield: 1.92%
Free cash flow yield: 4.86%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 69.11%
Operating margin: 22.87%
Net margin: 11.18%
Return on equity: 2.89%
Return on assets: 1.94%
Return on invested capital: 2.91%

Financial health

Debt / equity: 0.37×
Current ratio: 1.41×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

1.1B USD+16.50%

Operating income

249.31M USD+101.50%

Net income

112.09M USD+131.21M USD

Financial statements: Income statement
Metric (USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	1.1B USD	943.55M USD	791.01M USD	704.87M USD	578.57M USD
Cost of goods sold	348.16M USD	315.73M USD	249.77M USD	214.89M USD	151.77M USD
Gross profit	751.12M USD	627.82M USD	541.24M USD	489.98M USD	426.8M USD
Research and development	54.62M USD	48.78M USD	35.33M USD	32.81M USD	28.34M USD
Selling, general, and administrative	306.64M USD	268.69M USD	187.36M USD	184.56M USD	162.09M USD
Operating expenses	501.81M USD	504.09M USD	399.16M USD	400.53M USD	366.48M USD
Interest expense	77.54M USD	146.27M USD	205.92M USD	155.33M USD	127.01M USD
Depreciation and amortization	140.55M USD	186.63M USD	176.47M USD	183.17M USD	176.06M USD
Operating income	249.31M USD	123.73M USD	142.08M USD	89.45M USD	60.32M USD
Net income	112.09M USD	−19.13M USD	−51.33M USD	−51.46M USD	−47.12M USD

Company facts updated Oct 8, 2026.

Earnings

EPS beat rate: 70%; 7 beats, 2 misses, 1 met estimate
Average EPS surprise: +41.73%; 10 comparable reports
Latest EPS result: 0.43; Estimate 0.4 · Beat by 8.04%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

17 ratings

Strong buy16%

Buy1588%

Hold16%

Sell00%

Strong sell00%

Recent analyst actions

12 institutions

WAY peers

AMGN

Amgen Inc.

$407.44

-1.37%

GILD

Gilead Sciences, Inc.

$147.1

+0.17%

ISRG

Intuitive Surgical, Inc.

$415.41

+0.21%

VRTX

Vertex Pharmaceuticals Incorporated

$503.25

-0.47%

SNY

Sanofi

$40.23

+0.07%

MRNA

Moderna, Inc.

$197

+0.26%

Continue in GoAI

Research WAY

AI-generated and delayed market data for informational and educational purposes only. Not investment advice.

Company profile

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

61/ 100

GoAI Score

Buy

Valuation

Deep Value

Sentiment

Bullish

Risk

Elevated Risk

Momentum

Weakening

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Company website

Industry: Medical - Healthcare Information Services
Sector: Healthcare
Headquarters: US
CEO: Matthew J. Hawkins
Listed since: Jun 7, 2024
Employees: 1,700

Market position

Day range

Current $26.48

$25.78$26.705

52-week range

Current $26.48

$17.26$40.35

Open: $25.78
Previous close: $25.77
Volume: 2.09M; 0.82× average
Average volume: 2.55M; Average daily volume
Market cap: 5.08B USD
Beta: 0.07; Market reference 1
50-day average: $24.8092; +6.73% above average
200-day average: $24.2807; +9.06% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 7.26B USD
P/E (TTM): 36.78×
P/B (TTM): 1.27×
P/S (TTM): 4.21×
EV / EBITDA: 18.61×
Earnings yield: 1.92%
Free cash flow yield: 4.86%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 69.11%
Operating margin: 22.87%
Net margin: 11.18%
Return on equity: 2.89%
Return on assets: 1.94%
Return on invested capital: 2.91%

Financial health

Debt / equity: 0.37×
Current ratio: 1.41×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

1.1B USD+16.50%

Operating income

249.31M USD+101.50%

Net income

112.09M USD+131.21M USD

Financial statements: Income statement
Metric (USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	1.1B USD	943.55M USD	791.01M USD	704.87M USD	578.57M USD
Cost of goods sold	348.16M USD	315.73M USD	249.77M USD	214.89M USD	151.77M USD
Gross profit	751.12M USD	627.82M USD	541.24M USD	489.98M USD	426.8M USD
Research and development	54.62M USD	48.78M USD	35.33M USD	32.81M USD	28.34M USD
Selling, general, and administrative	306.64M USD	268.69M USD	187.36M USD	184.56M USD	162.09M USD
Operating expenses	501.81M USD	504.09M USD	399.16M USD	400.53M USD	366.48M USD
Interest expense	77.54M USD	146.27M USD	205.92M USD	155.33M USD	127.01M USD
Depreciation and amortization	140.55M USD	186.63M USD	176.47M USD	183.17M USD	176.06M USD
Operating income	249.31M USD	123.73M USD	142.08M USD	89.45M USD	60.32M USD
Net income	112.09M USD	−19.13M USD	−51.33M USD	−51.46M USD	−47.12M USD

Company facts updated Oct 8, 2026.

Earnings

EPS beat rate: 70%; 7 beats, 2 misses, 1 met estimate
Average EPS surprise: +41.73%; 10 comparable reports
Latest EPS result: 0.43; Estimate 0.4 · Beat by 8.04%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

17 ratings

Strong buy16%

Buy1588%

Hold16%

Sell00%

Strong sell00%

Recent analyst actions

12 institutions

WAY peers

AMGN

Amgen Inc.

$407.44

-1.37%

GILD

Gilead Sciences, Inc.

$147.1

+0.17%

ISRG

Intuitive Surgical, Inc.

$415.41

+0.21%

VRTX

Vertex Pharmaceuticals Incorporated

$503.25

-0.47%

SNY

Sanofi

$40.23

+0.07%

MRNA

Moderna, Inc.

$197

+0.26%

Continue in GoAI

Research WAY

AI-generated and delayed market data for informational and educational purposes only. Not investment advice.

Waystar Holding Corp.

WAY company overview

Company profile

Waystar Holding Corp.

WAY company overview

GoAI snapshot

Company profile

Market position

Financials

Financial snapshot

Valuation & yield

Profitability & efficiency

Financial health

Financial statements

Margin trends

Income trends

Earnings

EPS: actual versus estimate

Revenue: actual versus estimate

Analyst ratings

Rating distribution

Recent analyst actions

WAY peers

Continue in GoAI

WAY company overview

Company profile

WAY company overview

GoAI snapshot

Company profile

Market position

Financials

Financial snapshot

Valuation & yield

Profitability & efficiency

Financial health

Financial statements

Margin trends

Income trends

Earnings

EPS: actual versus estimate

Revenue: actual versus estimate

Analyst ratings

Rating distribution

Recent analyst actions

WAY peers

Continue in GoAI